bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.270
-0.060 (-4.51%)
Nov 20, 2024, 4:00 PM EST - Market closed
bioAffinity Technologies Market Cap
bioAffinity Technologies has a market cap or net worth of $19.79 million as of November 21, 2024. Its market cap has increased by 62.13% in one year.
Market Cap
19.79M
Enterprise Value
20.76M
1-Year Change
62.13%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since the IPO on September 1, 2022, bioAffinity Technologies's market cap has decreased from $44.99M to $19.79M, a decrease of -56.01%. That is a compound annual growth rate of -30.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 19.79M | 41.65% |
| Dec 29, 2023 | 13.97M | 4.34% |
| Dec 30, 2022 | 13.39M | -70.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Spruce Biosciences | 20.24M |
| Bionano Genomics | 20.08M |
| ProMIS Neurosciences | 20.07M |
| iBio, Inc. | 20.04M |
| Movano | 19.97M |
| Forte Biosciences | 19.79M |
| Unity Biotechnology | 19.71M |
| NeuroSense Therapeutics | 19.28M |